<DOC>
	<DOCNO>NCT00213395</DOCNO>
	<brief_summary>Noninvasive ventilation ( NIV ) major therapeutic option manage patient acute hypercapnic respiratory failure ( AHRF ) . Otherwise , patient-ventilator interface determinant get optimal NIV efficacy parallel ventilatory comfort . Facial mask NIV associate deleterious consequence like gas leak around mask , skin breakdown ( especially nasal bridge ) , claustrophobia mask discomfort . In order limit side effect , cephalic interface recently design . Cephalic mask cover whole anterior surface face excessive mask fit pressure therefore spread large surface outside nose area . However , mask high volume may interfere NIV efficacy may also induce claustrophobic sensation . The aim study compare clinical efficacy tolerance cephalic mask versus conventional oronasal mask AHRF .</brief_summary>
	<brief_title>Clinical Efficacy Cephalic Mask Noninvasive Ventilation During Acute Hypercapnic Respiratory Failure</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Hypercapnia</mesh_term>
	<criteria>Acute hypercapnic respiratory failure Indication noninvasive ventilation Requirement endotracheal intubation Proven pulmonary embolism Present previous history ophthalmologic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Noninvasive ventilation</keyword>
	<keyword>Acute hypercapnic respiratory failure</keyword>
	<keyword>Cephalic mask</keyword>
	<keyword>Facial Mask</keyword>
</DOC>